Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is used in treating protein deficiency in healthcare applications. It is also used in production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation.
Based on the Human Plasma Fractionation market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Human Plasma Fractionation market covered in Chapter 5:
Kedrion
CSL Ltd.
Green Cross Corporation
Octapharma AG
Bio Product Laboratory
Grifols SA
Sanquin
Biotest
Shire
Japan Blood Products Organization
Shanghai RAAS Blood Products
Laboratoire Franais du Fractionnement et des Biotechnologies
Baxter International Inc.
China Biologic Products
In Chapter 6, on the basis of types, the Human Plasma Fractionation market from 2015 to 2025 is primarily split into:
Albumin
Immunoglobulins
Coagulation Factor Concentrates
Others
In Chapter 7, on the basis of applications, the Human Plasma Fractionation market from 2015 to 2025 covers:
Neurology
Hematology
Immunology
Critical Care
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Human Plasma Fractionation Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Kedrion
5.1.1 Kedrion Company Profile
5.1.2 Kedrion Business Overview
5.1.3 Kedrion Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Kedrion Human Plasma Fractionation Products Introduction
5.2 CSL Ltd.
5.2.1 CSL Ltd. Company Profile
5.2.2 CSL Ltd. Business Overview
5.2.3 CSL Ltd. Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 CSL Ltd. Human Plasma Fractionation Products Introduction
5.3 Green Cross Corporation
5.3.1 Green Cross Corporation Company Profile
5.3.2 Green Cross Corporation Business Overview
5.3.3 Green Cross Corporation Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Green Cross Corporation Human Plasma Fractionation Products Introduction
5.4 Octapharma AG
5.4.1 Octapharma AG Company Profile
5.4.2 Octapharma AG Business Overview
5.4.3 Octapharma AG Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Octapharma AG Human Plasma Fractionation Products Introduction
5.5 Bio Product Laboratory
5.5.1 Bio Product Laboratory Company Profile
5.5.2 Bio Product Laboratory Business Overview
5.5.3 Bio Product Laboratory Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Bio Product Laboratory Human Plasma Fractionation Products Introduction
5.6 Grifols SA
5.6.1 Grifols SA Company Profile
5.6.2 Grifols SA Business Overview
5.6.3 Grifols SA Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Grifols SA Human Plasma Fractionation Products Introduction
5.7 Sanquin
5.7.1 Sanquin Company Profile
5.7.2 Sanquin Business Overview
5.7.3 Sanquin Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Sanquin Human Plasma Fractionation Products Introduction
5.8 Biotest
5.8.1 Biotest Company Profile
5.8.2 Biotest Business Overview
5.8.3 Biotest Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Biotest Human Plasma Fractionation Products Introduction
5.9 Shire
5.9.1 Shire Company Profile
5.9.2 Shire Business Overview
5.9.3 Shire Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Shire Human Plasma Fractionation Products Introduction
5.10 Japan Blood Products Organization
5.10.1 Japan Blood Products Organization Company Profile
5.10.2 Japan Blood Products Organization Business Overview
5.10.3 Japan Blood Products Organization Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Japan Blood Products Organization Human Plasma Fractionation Products Introduction
5.11 Shanghai RAAS Blood Products
5.11.1 Shanghai RAAS Blood Products Company Profile
5.11.2 Shanghai RAAS Blood Products Business Overview
5.11.3 Shanghai RAAS Blood Products Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Shanghai RAAS Blood Products Human Plasma Fractionation Products Introduction
5.12 Laboratoire Franais du Fractionnement et des Biotechnologies
5.12.1 Laboratoire Franais du Fractionnement et des Biotechnologies Company Profile
5.12.2 Laboratoire Franais du Fractionnement et des Biotechnologies Business Overview
5.12.3 Laboratoire Franais du Fractionnement et des Biotechnologies Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Laboratoire Franais du Fractionnement et des Biotechnologies Human Plasma Fractionation Products Introduction
5.13 Baxter International Inc.
5.13.1 Baxter International Inc. Company Profile
5.13.2 Baxter International Inc. Business Overview
5.13.3 Baxter International Inc. Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Baxter International Inc. Human Plasma Fractionation Products Introduction
5.14 China Biologic Products
5.14.1 China Biologic Products Company Profile
5.14.2 China Biologic Products Business Overview
5.14.3 China Biologic Products Human Plasma Fractionation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 China Biologic Products Human Plasma Fractionation Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Human Plasma Fractionation Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Human Plasma Fractionation Sales and Market Share by Types (2015-2020)
6.1.2 Global Human Plasma Fractionation Revenue and Market Share by Types (2015-2020)
6.1.3 Global Human Plasma Fractionation Price by Types (2015-2020)
6.2 Global Human Plasma Fractionation Market Forecast by Types (2020-2025)
6.2.1 Global Human Plasma Fractionation Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Human Plasma Fractionation Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Human Plasma Fractionation Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Human Plasma Fractionation Sales, Price and Growth Rate of Albumin
6.3.2 Global Human Plasma Fractionation Sales, Price and Growth Rate of Immunoglobulins
6.3.3 Global Human Plasma Fractionation Sales, Price and Growth Rate of Coagulation Factor Concentrates
6.3.4 Global Human Plasma Fractionation Sales, Price and Growth Rate of Others
6.4 Global Human Plasma Fractionation Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Albumin Market Revenue and Sales Forecast (2020-2025)
6.4.2 Immunoglobulins Market Revenue and Sales Forecast (2020-2025)
6.4.3 Coagulation Factor Concentrates Market Revenue and Sales Forecast (2020-2025)
6.4.4 Others Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Human Plasma Fractionation Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Human Plasma Fractionation Sales and Market Share by Applications (2015-2020)
7.1.2 Global Human Plasma Fractionation Revenue and Market Share by Applications (2015-2020)
7.2 Global Human Plasma Fractionation Market Forecast by Applications (2020-2025)
7.2.1 Global Human Plasma Fractionation Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Human Plasma Fractionation Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Human Plasma Fractionation Revenue, Sales and Growth Rate of Neurology (2015-2020)
7.3.2 Global Human Plasma Fractionation Revenue, Sales and Growth Rate of Hematology (2015-2020)
7.3.3 Global Human Plasma Fractionation Revenue, Sales and Growth Rate of Immunology (2015-2020)
7.3.4 Global Human Plasma Fractionation Revenue, Sales and Growth Rate of Critical Care (2015-2020)
7.3.5 Global Human Plasma Fractionation Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Human Plasma Fractionation Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Neurology Market Revenue and Sales Forecast (2020-2025)
7.4.2 Hematology Market Revenue and Sales Forecast (2020-2025)
7.4.3 Immunology Market Revenue and Sales Forecast (2020-2025)
7.4.4 Critical Care Market Revenue and Sales Forecast (2020-2025)
7.4.5 Others Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Human Plasma Fractionation Sales by Regions (2015-2020)
8.2 Global Human Plasma Fractionation Market Revenue by Regions (2015-2020)
8.3 Global Human Plasma Fractionation Market Forecast by Regions (2020-2025)
9 North America Human Plasma Fractionation Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Human Plasma Fractionation Market Sales and Growth Rate (2015-2020)
9.3 North America Human Plasma Fractionation Market Revenue and Growth Rate (2015-2020)
9.4 North America Human Plasma Fractionation Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Human Plasma Fractionation Market Analysis by Country
9.6.1 U.S. Human Plasma Fractionation Sales and Growth Rate
9.6.2 Canada Human Plasma Fractionation Sales and Growth Rate
9.6.3 Mexico Human Plasma Fractionation Sales and Growth Rate
10 Europe Human Plasma Fractionation Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Human Plasma Fractionation Market Sales and Growth Rate (2015-2020)
10.3 Europe Human Plasma Fractionation Market Revenue and Growth Rate (2015-2020)
10.4 Europe Human Plasma Fractionation Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Human Plasma Fractionation Market Analysis by Country
10.6.1 Germany Human Plasma Fractionation Sales and Growth Rate
10.6.2 United Kingdom Human Plasma Fractionation Sales and Growth Rate
10.6.3 France Human Plasma Fractionation Sales and Growth Rate
10.6.4 Italy Human Plasma Fractionation Sales and Growth Rate
10.6.5 Spain Human Plasma Fractionation Sales and Growth Rate
10.6.6 Russia Human Plasma Fractionation Sales and Growth Rate
11 Asia-Pacific Human Plasma Fractionation Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Human Plasma Fractionation Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Human Plasma Fractionation Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Human Plasma Fractionation Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Human Plasma Fractionation Market Analysis by Country
11.6.1 China Human Plasma Fractionation Sales and Growth Rate
11.6.2 Japan Human Plasma Fractionation Sales and Growth Rate
11.6.3 South Korea Human Plasma Fractionation Sales and Growth Rate
11.6.4 Australia Human Plasma Fractionation Sales and Growth Rate
11.6.5 India Human Plasma Fractionation Sales and Growth Rate
12 South America Human Plasma Fractionation Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Human Plasma Fractionation Market Sales and Growth Rate (2015-2020)
12.3 South America Human Plasma Fractionation Market Revenue and Growth Rate (2015-2020)
12.4 South America Human Plasma Fractionation Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Human Plasma Fractionation Market Analysis by Country
12.6.1 Brazil Human Plasma Fractionation Sales and Growth Rate
12.6.2 Argentina Human Plasma Fractionation Sales and Growth Rate
12.6.3 Columbia Human Plasma Fractionation Sales and Growth Rate
13 Middle East and Africa Human Plasma Fractionation Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Human Plasma Fractionation Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Human Plasma Fractionation Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Human Plasma Fractionation Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Human Plasma Fractionation Market Analysis by Country
13.6.1 UAE Human Plasma Fractionation Sales and Growth Rate
13.6.2 Egypt Human Plasma Fractionation Sales and Growth Rate
13.6.3 South Africa Human Plasma Fractionation Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Human Plasma Fractionation Market Size and Growth Rate 2015-2025
Table Human Plasma Fractionation Key Market Segments
Figure Global Human Plasma Fractionation Market Revenue ($) Segment by Type from 2015-2020
Figure Global Human Plasma Fractionation Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Human Plasma Fractionation
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Kedrion Company Profile
Table Kedrion Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Summary: Get latest Market Research Reports on Human Plasma Fractionation. Industry analysis & Market Report on Human Plasma Fractionation is a syndicated market report, published as Global Human Plasma Fractionation Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Human Plasma Fractionation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.